Mining_NN risk_NN patterns_NNS in_IN medical_JJ data_NNS
In_IN this_DT paper_NN ,_, we_PRP discuss_VBP a_DT problem_NN of_IN finding_VBG risk_NN patterns_NNS in_IN medical_JJ data_NNS ._.
We_PRP define_VBP risk_NN patterns_NNS by_IN a_DT statistical_JJ metric_NN ,_, relative_JJ risk_NN ,_, which_WDT has_VBZ been_VBN widely_RB used_VBN in_IN epidemiological_JJ research_NN ._.
We_PRP characterise_VBP the_DT problem_NN of_IN mining_NN risk_NN patterns_NNS as_IN an_DT optimal_JJ rule_NN discovery_NN problem_NN ._.
We_PRP study_VBD an_DT anti-monotone_JJ property_NN for_IN mining_NN optimal_JJ risk_NN pattern_NN sets_NNS and_CC present_VB an_DT algorithm_NN to_TO make_VB use_NN of_IN the_DT property_NN in_IN risk_NN pattern_NN discovery_NN ._.
The_DT method_NN has_VBZ been_VBN applied_VBN to_TO a_DT real_JJ world_NN data_NNS set_VBN to_TO find_VB patterns_NNS associated_VBN with_IN an_DT allergic_JJ event_NN for_IN ACE_NN inhibitors_NNS ._.
The_DT algorithm_NN has_VBZ generated_VBN some_DT useful_JJ results_NNS for_IN medical_JJ researchers_NNS ._.
ality_NN of_IN the_DT data_NNS are_VBP of_IN great_JJ concern_NN in_IN terms_NNS of_IN the_DT predictive_JJ accuracy_NN of_IN the_DT models_NNS -LRB-_-LRB- Tsumoto_NNP 2000_CD -RRB-_-RRB- ._.
This_DT is_VBZ due_JJ to_TO the_DT fact_NN that_IN hospitals_NNS collect_VBP the_DT data_NNS without_IN any_DT specific_JJ research_NN purpose_NN -LRB-_-LRB- =_JJ -_: =_JJ Li_NNP et_FW al._FW 2005_CD -_: =--RRB-_NN ._.
Therefore_RB ,_, medical_JJ databases_NNS contain_VBP many_JJ features_NNS that_WDT suffer_VBP data_NN mining_NN tools_NNS and_CC techniques_NNS -LRB-_-LRB- Tsumoto_NNP 2000_CD -RRB-_-RRB- ._.
For_IN example_NN ,_, missing_VBG data_NNS in_IN medical_JJ databases_NNS must_MD be_VB treated_VBN or_CC eliminated_VBN to_TO achie_VB
nsive_JJ amounts_NNS of_IN data_NNS collected_VBN and_CC stored_VBN by_IN medical_JJ information_NN systems_NNS ._.
Through_IN intelligent_JJ data_NN analysis_NN techniques_NNS ,_, these_DT databases_NNS can_MD provide_VB rich_JJ information_NN resources_NNS for_IN decision_NN makers_NNS ._.
In_IN =_JJ -_: =[_NN 9_CD -RRB-_-RRB- -_: =_SYM -_: the_DT authors_NNS study_VBP the_DT specific_JJ problem_NN of_IN finding_VBG risk_NN patterns_NNS in_IN medical_JJ data_NNS ._.
-LRB-_-LRB- 10_CD -RRB-_-RRB- presents_VBZ a_DT pattern_NN discovery_NN methodology_NN for_IN the_DT analysis_NN of_IN relationships_NNS between_IN events_NNS in_IN medical_JJ records_NNS ._.
In_IN
rn_NN discovery_NN has_VBZ been_VBN applied_VBN to_TO data_NNS from_IN a_DT variety_NN of_IN applications_NNS ,_, for_IN example_NN ,_, world_NN wide_JJ web_NN transactions_NNS -LRB-_-LRB- Mobasher_NNP et_FW al._FW ,_, 1996_CD -RRB-_-RRB- ,_, marketing_NN information_NN -LRB-_-LRB- Shaw_NNP et_FW al._FW ,_, 2001_CD -RRB-_-RRB- ,_, and_CC medical_JJ signals_NNS -LRB-_-LRB- =_JJ -_: =_JJ Li_NNP et_FW al._FW ,_, 2005_CD -_: =--RRB-_NN ._.
More_RBR recently_RB ,_, there_EX has_VBZ been_VBN an_DT increased_VBN interest_NN in_IN applying_VBG techniques_NNS for_IN discovering_VBG patterns_NNS to_TO sequences_NNS corresponding_VBG to_TO genomic_JJ data_NNS -LRB-_-LRB- Wang_NNP et_FW al._FW ,_, 1999_CD -RRB-_-RRB- ._.
Of_IN particular_JJ importance_NN in_IN compu_NN
a_DT small_JJ population_NN ._.
For_IN example_NN ,_, a_DT very_RB small_JJ percentage_NN of_IN people_NNS are_VBP HIV_NN positive_JJ or_CC develop_VB cancer_NN ._.
However_RB ,_, risk_NN patterns_NNS are_VBP also_RB not_RB exactly_RB outliers_NNS or_CC exceptions_NNS ,_, which_WDT also_RB has_VBZ been_VBN studied_VBN =_JJ -_: =[_NN 8_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT reason_NN is_VBZ that_IN among_IN the_DT small_JJ percentage_NN of_IN positive_JJ samples_NNS ,_, we_PRP do_VBP want_VB to_TO see_VB frequent_JJ patterns_NNS ._.
Hence_RB this_DT requires_VBZ a_DT special_JJ measurement_NN of_IN interestingness_NN ._.
There_EX are_VBP a_DT lot_NN of_IN proposed_VBN inte_NN
mining_NN methods_NNS needs_VBZ further_JJ improving_NN ._.
For_IN example_NN ,_, association_NN rule_NN mining_NN is_VBZ still_RB inefficient_JJ when_WRB the_DT minimum_JJ support_NN is_VBZ low_JJ ._.
Some_DT optimal_JJ rule_NN discovery_NN methods_NNS ,_, e.g._FW PC_NN optimality_NN rule_NN mining_NN =_JJ -_: =[_NN 2_CD -RRB-_-RRB- -_: =_JJ -_: and_CC optimal_JJ class_NN association_NN rule_NN set_NN mining_NN -LRB-_-LRB- 9_CD -RRB-_-RRB- are_VBP significantly_RB more_RBR efficient_JJ and_CC less_RBR restricted_JJ by_IN the_DT minimum_JJ support_NN ._.
In_IN this_DT paper_NN ,_, we_PRP shall_MD show_VB that_IN mining_NN risk_NN patterns_NNS can_MD be_VB considered_VBN
owever_RB ,_, a_DT lot_NN of_IN data_NN mining_NN methods_NNS have_VBP not_RB achieved_VBN this_DT goal_NN yet_RB ._.
For_IN example_NN ,_, it_PRP is_VBZ difficult_JJ to_TO interpret_VB results_NNS from_IN neural_JJ networks_NNS ._.
Decision_NN tree_NN ,_, typified_VBN by_IN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, can_MD be_VB extended_VBN to_TO rules_NNS =_JJ -_: =[_NN 15_CD -RRB-_-RRB- -_: =_JJ -_: ,_, and_CC their_PRP$ results_NNS are_VBP more_RBR straightforward_JJ to_TO interpret_VB ._.
They_PRP have_VBP been_VBN used_VBN to_TO solve_VB classification_NN problems_NNS in_IN medical_JJ data_NN analysis_NN -LRB-_-LRB- 10_CD ,_, 19_CD -RRB-_-RRB- ._.
However_RB ,_, C4_NN .5_NN does_VBZ not_RB work_VB well_RB on_IN the_DT skewed_JJ cases_NNS
often_RB unmanageable_JJ ._.
For_IN example_NN it_PRP is_VBZ quite_RB impossible_JJ for_IN domain_NN experts_NNS to_TO review_VB a_DT huge_JJ number_NN of_IN association_NN rules_NNS ._.
Association_NN rule_NN mining_NN has_VBZ been_VBN used_VBN in_IN medical_JJ data_NN analysis_NN ._.
Brossette_NNP et_NNP al_NNP =_JJ -_: =[_NN 4_CD -RRB-_-RRB- -_: =_SYM -_: found_VBN association_NN rules_NNS in_IN hospital_NN infectionscontrol_NN and_CC public_JJ surveillance_NN data_NNS ._.
Paetz_NNP et_FW al_FW -LRB-_-LRB- 13_CD -RRB-_-RRB- found_VBD association_NN rules_NNS in_IN septic_JJ shock_NN patient_NN data_NNS ._.
Too_RB many_JJ rules_NNS is_VBZ a_DT problem_NN in_IN both_DT projects_NNS
ty_NN if_IN -LRB-_-LRB- supp_NN -LRB-_-LRB- P_NN x_NN -RRB-_-RRB- =_JJ supp_NN -LRB-_-LRB- P_NN -RRB-_-RRB- -RRB-_-RRB- then_RB pattern_NN P_NN x_NN and_CC all_DT its_PRP$ super_JJ patterns_NNS do_VBP not_RB occur_VB in_IN the_DT optimal_JJ risk_NN pattern_NN set_NN ._.
This_DT corollary_NN is_VBZ closely_RB association_NN with_IN non-redundant_JJ association_NN rule_NN mining_NN =_JJ -_: =[_NN 18_CD -RRB-_-RRB- -_: =_SYM -_: because_IN P_NN is_VBZ a_DT proper_JJ generator_NN of_IN P_NN x_NN when_WRB supp_NN -LRB-_-LRB- P_NN x_NN -RRB-_-RRB- =_JJ supp_NN -LRB-_-LRB- P_NN -RRB-_-RRB- ._.
A_DT non-redundant_JJ association_NN rule_NN set_NN is_VBZ generated_VBN from_IN a_DT set_NN of_IN minimal_JJ generators_NNS ._.
Consider_VB this_DT corollary_NN is_VBZ a_DT special_JJ case_NN for_IN the_DT
Decision_NN tree_NN ,_, typified_VBN by_IN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, can_MD be_VB extended_VBN to_TO rules_NNS -LRB-_-LRB- 15_CD -RRB-_-RRB- ,_, and_CC their_PRP$ results_NNS are_VBP more_RBR straightforward_JJ to_TO interpret_VB ._.
They_PRP have_VBP been_VBN used_VBN to_TO solve_VB classification_NN problems_NNS in_IN medical_JJ data_NNS analysis_NN =_JJ -_: =[_NN 10_CD ,_, 19_CD -RRB-_-RRB- -_: =_SYM -_: ._.
However_RB ,_, C4_NN .5_NN does_VBZ not_RB work_VB well_RB on_IN the_DT skewed_JJ cases_NNS in_IN medical_JJ data_NNS where_WRB the_DT normal_JJ population_NN greatly_RB outnumbers_VBZ the_DT population_NN with_IN disease_NN ._.
Other_JJ rule_NN based_VBN classification_NN methods_NNS ,_, e.g._FW CN2_NN -LRB-_-LRB- 7_CD ,_,
tic_JJ shock_NN patient_NN data_NNS ._.
Too_RB many_JJ rules_NNS is_VBZ a_DT problem_NN in_IN both_DT projects_NNS ._.
Sequence_NN patterns_NNS have_VBP been_VBN found_VBN in_IN chronic_JJ hepatitis_NN data_NNS by_IN Ohsaki_FW et_FW al_FW -LRB-_-LRB- 12_CD -RRB-_-RRB- ,_, and_CC on_IN adverse_JJ drug_NN reaction_NN data_NNS by_IN Chen_NNP et_FW al_FW =_JJ -_: =[_NN 5_CD -RRB-_-RRB- -_: =_SYM -_: ._.
However_RB ,_, these_DT cases_NNS result_VBP in_IN too_RB many_JJ trivial_JJ and_CC similar_JJ patterns_NNS which_WDT is_VBZ also_RB a_DT problem_NN in_IN the_DT research_NN ._.
Parameter_NN Tuning_VBG Many_JJ fast_JJ heuristic_NN data_NN mining_NN methods_NNS need_VBP a_DT lot_NN of_IN tuning_NN and_CC they_PRP a_DT
tio_NN ._.
Odds_NNS ratio_NN and_CC relative_JJ risk_NN are_VBP consistent_JJ ._.
A_DT larger_JJR odds_NNS ratio_NN leads_VBZ to_TO a_DT larger_JJR relative_JJ risk_NN ,_, and_CC vice_NN versa_RB ._.
Under_IN the_DT rare-disease_NN assumption_NN ,_, the_DT odds_NNS ratio_NN approximates_VBZ the_DT relative_JJ risk_NN =_JJ -_: =[_NN 3_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT odds_NNS ratio_NN is_VBZ usually_RB used_VBN in_IN case_NN control_NN studies_NNS ._.
In_IN this_DT paper_NN we_PRP make_VBP use_NN of_IN the_DT relative_JJ risk_NN ._. ._.
sDefinition_NN 1_CD Risk_NN patterns_NNS are_VBP frequent_JJ patterns_NNS whose_WP$ relative_JJ risks_NNS are_VBP higher_JJR than_IN a_DT thre_NN
association_NN rules_NNS ._.
Association_NN rule_NN mining_NN has_VBZ been_VBN used_VBN in_IN medical_JJ data_NN analysis_NN ._.
Brossette_NNP et_NNP al_NNP -LRB-_-LRB- 4_CD -RRB-_-RRB- found_VBD association_NN rules_NNS in_IN hospital_NN infectionscontrol_NN and_CC public_JJ surveillance_NN data_NNS ._.
Paetz_NNP et_FW al_FW =_JJ -_: =[_NN 13_CD -RRB-_-RRB- -_: =_SYM -_: found_VBN association_NN rules_NNS in_IN septic_JJ shock_NN patient_NN data_NNS ._.
Too_RB many_JJ rules_NNS is_VBZ a_DT problem_NN in_IN both_DT projects_NNS ._.
Sequence_NN patterns_NNS have_VBP been_VBN found_VBN in_IN chronic_JJ hepatitis_NN data_NNS by_IN Ohsaki_FW et_FW al_FW -LRB-_-LRB- 12_CD -RRB-_-RRB- ,_, and_CC on_IN adverse_JJ dr_NN
Nervous_JJ system_NN ''_'' =_JJ No_NNP Most_NNP found_VBD patterns_NNS are_VBP of_IN great_JJ interest_NN to_TO domain_NN experts_NNS and_CC verified_VBN by_IN them_PRP ._.
We_PRP have_VBP conducted_VBN further_JJ statistical_JJ analysis_NN ,_, e.g._FW the_DT survival_NN analysis_NN and_CC significance_NN test_NN =_JJ -_: =[_NN 16_CD -RRB-_-RRB- -_: =_JJ -_: ,_, to_TO evaluate_VB the_DT statistical_JJ significance_NN of_IN found_VBN patterns_NNS ._.
The_DT survival_NN analysis_NN is_VBZ concerned_VBN with_IN the_DT modelling_NN of_IN `_`` lifetime_NN '_'' data_NNS ._.
We_PRP estimate_VBP the_DT survivor_NN function_NN S_NN -LRB-_-LRB- t_NN -RRB-_-RRB- ,_, by_IN the_DT probability_NN of_IN no_DT
19_CD -RRB-_-RRB- ._.
However_RB ,_, C4_NN .5_NN does_VBZ not_RB work_VB well_RB on_IN the_DT skewed_JJ cases_NNS in_IN medical_JJ data_NNS where_WRB the_DT normal_JJ population_NN greatly_RB outnumbers_VBZ the_DT population_NN with_IN disease_NN ._.
Other_JJ rule_NN based_VBN classification_NN methods_NNS ,_, e.g._FW CN2_NN =_JJ -_: =[_NN 7_CD ,_, 6_CD -RRB-_-RRB- -_: =_JJ -_: ,_, suffer_VBP the_DT same_JJ problem_NN ._.
Amount_NN of_IN results_NNS The_DT quantity_NN of_IN output_NN from_IN many_JJ data_NNS mining_NN method_NN is_VBZ often_RB unmanageable_JJ ._.
For_IN example_NN it_PRP is_VBZ quite_RB impossible_JJ for_IN domain_NN experts_NNS to_TO review_VB a_DT huge_JJ number_NN of_IN
s._VBN Hence_RB this_DT requires_VBZ a_DT special_JJ measurement_NN of_IN interestingness_NN ._.
There_EX are_VBP a_DT lot_NN of_IN proposed_VBN interestingness_NN criteria_NNS for_IN association_NN rule_NN mining_NN ,_, and_CC a_DT comprehensive_JJ comparison_NN has_VBZ been_VBN conducted_VBN in_IN =_JJ -_: =[_NN 17_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Some_DT evaluation_NN work_NN on_IN medical_JJ data_NNS sets_NNS has_VBZ been_VBN reported_VBN in_IN -LRB-_-LRB- 11_CD -RRB-_-RRB- ._.
However_RB ,_, most_JJS criteria_NNS do_VBP not_RB make_VB sense_NN to_TO medical_JJ practitioners_NNS ._.
So_RB we_PRP should_MD use_VB those_DT have_VBP been_VBN used_VBN in_IN medical_JJ research_NN ,_, suc_NN
e_LS are_VBP a_DT lot_NN of_IN proposed_VBN interestingness_NN criteria_NNS for_IN association_NN rule_NN mining_NN ,_, and_CC a_DT comprehensive_JJ comparison_NN has_VBZ been_VBN conducted_VBN in_IN -LRB-_-LRB- 17_CD -RRB-_-RRB- ._.
Some_DT evaluation_NN work_NN on_IN medical_JJ data_NNS sets_NNS has_VBZ been_VBN reported_VBN in_IN =_JJ -_: =[_NN 11_CD -RRB-_-RRB- -_: =_SYM -_: ._.
However_RB ,_, most_JJS criteria_NNS do_VBP not_RB make_VB sense_NN to_TO medical_JJ practitioners_NNS ._.
So_RB we_PRP should_MD use_VB those_DT have_VBP been_VBN used_VBN in_IN medical_JJ research_NN ,_, such_JJ as_IN ,_, relative_JJ risk_NN and_CC odds_NNS ratio_NN ._.
In_IN the_DT paper_NN ,_, we_PRP will_MD present_VB an_DT
le_FW ,_, association_NN rule_NN mining_NN is_VBZ still_RB inefficient_JJ when_WRB the_DT minimum_JJ support_NN is_VBZ low_JJ ._.
Some_DT optimal_JJ rule_NN discovery_NN methods_NNS ,_, e.g._FW PC_NN optimality_NN rule_NN mining_NN -LRB-_-LRB- 2_CD -RRB-_-RRB- and_CC optimal_JJ class_NN association_NN rule_NN set_NN mining_NN =_JJ -_: =[_NN 9_CD -RRB-_-RRB- -_: =_SYM -_: are_VBP significantly_RB more_RBR efficient_JJ and_CC less_RBR restricted_JJ by_IN the_DT minimum_JJ support_NN ._.
In_IN this_DT paper_NN ,_, we_PRP shall_MD show_VB that_IN mining_NN risk_NN patterns_NNS can_MD be_VB considered_VBN an_DT optimal_JJ rule_NN mining_NN problem_NN ,_, and_CC an_DT efficient_JJ
19_CD -RRB-_-RRB- ._.
However_RB ,_, C4_NN .5_NN does_VBZ not_RB work_VB well_RB on_IN the_DT skewed_JJ cases_NNS in_IN medical_JJ data_NNS where_WRB the_DT normal_JJ population_NN greatly_RB outnumbers_VBZ the_DT population_NN with_IN disease_NN ._.
Other_JJ rule_NN based_VBN classification_NN methods_NNS ,_, e.g._FW CN2_NN =_JJ -_: =[_NN 7_CD ,_, 6_CD -RRB-_-RRB- -_: =_JJ -_: ,_, suffer_VBP the_DT same_JJ problem_NN ._.
Amount_NN of_IN results_NNS The_DT quantity_NN of_IN output_NN from_IN many_JJ data_NNS mining_NN method_NN is_VBZ often_RB unmanageable_JJ ._.
For_IN example_NN it_PRP is_VBZ quite_RB impossible_JJ for_IN domain_NN experts_NNS to_TO review_VB a_DT huge_JJ number_NN of_IN
s_NN results_NNS are_VBP understandable_JJ ._.
However_RB ,_, a_DT lot_NN of_IN data_NN mining_NN methods_NNS have_VBP not_RB achieved_VBN this_DT goal_NN yet_RB ._.
For_IN example_NN ,_, it_PRP is_VBZ difficult_JJ to_TO interpret_VB results_NNS from_IN neural_JJ networks_NNS ._.
Decision_NN tree_NN ,_, typified_VBN by_IN =_JJ -_: =[_NN 14_CD -RRB-_-RRB- -_: =_JJ -_: ,_, can_MD be_VB extended_VBN to_TO rules_NNS -LRB-_-LRB- 15_CD -RRB-_-RRB- ,_, and_CC their_PRP$ results_NNS are_VBP more_RBR straightforward_JJ to_TO interpret_VB ._.
They_PRP have_VBP been_VBN used_VBN to_TO solve_VB classification_NN problems_NNS in_IN medical_JJ data_NN analysis_NN -LRB-_-LRB- 10_CD ,_, 19_CD -RRB-_-RRB- ._.
However_RB ,_, C4_NN .5_NN does_VBZ not_RB
Decision_NN tree_NN ,_, typified_VBN by_IN -LRB-_-LRB- 14_CD -RRB-_-RRB- ,_, can_MD be_VB extended_VBN to_TO rules_NNS -LRB-_-LRB- 15_CD -RRB-_-RRB- ,_, and_CC their_PRP$ results_NNS are_VBP more_RBR straightforward_JJ to_TO interpret_VB ._.
They_PRP have_VBP been_VBN used_VBN to_TO solve_VB classification_NN problems_NNS in_IN medical_JJ data_NNS analysis_NN =_JJ -_: =[_NN 10_CD ,_, 19_CD -RRB-_-RRB- -_: =_SYM -_: ._.
However_RB ,_, C4_NN .5_NN does_VBZ not_RB work_VB well_RB on_IN the_DT skewed_JJ cases_NNS in_IN medical_JJ data_NNS where_WRB the_DT normal_JJ population_NN greatly_RB outnumbers_VBZ the_DT population_NN with_IN disease_NN ._.
Other_JJ rule_NN based_VBN classification_NN methods_NNS ,_, e.g._FW CN2_NN -LRB-_-LRB- 7_CD ,_,
data_NNS ._.
Paetz_NNP et_FW al_FW -LRB-_-LRB- 13_CD -RRB-_-RRB- found_VBD association_NN rules_NNS in_IN septic_JJ shock_NN patient_NN data_NNS ._.
Too_RB many_JJ rules_NNS is_VBZ a_DT problem_NN in_IN both_DT projects_NNS ._.
Sequence_NN patterns_NNS have_VBP been_VBN found_VBN in_IN chronic_JJ hepatitis_NN data_NNS by_IN Ohsaki_FW et_FW al_FW =_JJ -_: =[_NN 12_CD -RRB-_-RRB- -_: =_JJ -_: ,_, and_CC on_IN adverse_JJ drug_NN reaction_NN data_NNS by_IN Chen_NNP et_FW al_FW -LRB-_-LRB- 5_CD -RRB-_-RRB- ._.
However_RB ,_, these_DT cases_NNS result_VBP in_IN too_RB many_JJ trivial_JJ and_CC similar_JJ patterns_NNS which_WDT is_VBZ also_RB a_DT problem_NN in_IN the_DT research_NN ._.
Parameter_NN Tuning_VBG Many_JJ fast_JJ heuristi_NNS
